These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 30444309)

  • 1. Prenatal heart block screening in mothers with SSA/SSB autoantibodies: Targeted screening protocol is a cost-effective strategy.
    Evers PD; Alsaied T; Anderson JB; Cnota JF; Divanovic AA
    Congenit Heart Dis; 2019 Mar; 14(2):221-229. PubMed ID: 30444309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early diagnosis and treatment of atrioventricular block in the fetus exposed to maternal anti-SSA/Ro-SSB/La antibodies: a prospective, observational, fetal kinetocardiogram-based study.
    Rein AJ; Mevorach D; Perles Z; Gavri S; Nadjari M; Nir A; Elchalal U
    Circulation; 2009 Apr; 119(14):1867-72. PubMed ID: 19332471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of complete heart block in children of mothers with anti-SSA/Ro and anti-SSB/La autoantibodies: detection and treatment of first-degree atrioventricular block.
    Mevorach D; Elchalal U; Rein AJ
    Curr Opin Rheumatol; 2009 Sep; 21(5):478-82. PubMed ID: 19584727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Home Monitoring for Fetal Heart Rhythm During Anti-Ro Pregnancies.
    Cuneo BF; Sonesson SE; Levasseur S; Moon-Grady AJ; Krishnan A; Donofrio MT; Raboisson MJ; Hornberger LK; Van Eerden P; Sinkovskaya E; Abuhamad A; Arya B; Szwast A; Gardiner H; Jacobs K; Freire G; Howley L; Lam A; Kaizer AM; Benson DW; Jaeggi E
    J Am Coll Cardiol; 2018 Oct; 72(16):1940-1951. PubMed ID: 30309472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Obstetric and perinatal outcome in anti-Ro/SSA-positive pregnant women: a prospective cohort study.
    Martínez-Sánchez N; Pérez-Pinto S; Robles-Marhuenda Á; Arnalich-Fernández F; Martín Cameán M; Hueso Zalvide E; Bartha JL
    Immunol Res; 2017 Apr; 65(2):487-494. PubMed ID: 28138914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of fetal echocardiographic surveillance in anti-SSA exposed fetuses at a large fetal cardiology center.
    Krishnan A; Arya B; Moak JP; Donofrio MT
    Prenat Diagn; 2014 Dec; 34(12):1207-12. PubMed ID: 24989941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of treatment with fluorinated glucocorticoids to the natural history of autoantibody-associated congenital heart block: retrospective review of the research registry for neonatal lupus.
    Saleeb S; Copel J; Friedman D; Buyon JP
    Arthritis Rheum; 1999 Nov; 42(11):2335-45. PubMed ID: 10555029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subclass distribution of maternal and neonatal anti-Ro(SSA) and La(SSB) antibodies in congenital heart block.
    Tseng CE; Caldwell K; Feit S; Chan EK; Buyon JP
    J Rheumatol; 1996 May; 23(5):925-32. PubMed ID: 8724310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The importance of the level of maternal anti-Ro/SSA antibodies as a prognostic marker of the development of cardiac neonatal lupus erythematosus a prospective study of 186 antibody-exposed fetuses and infants.
    Jaeggi E; Laskin C; Hamilton R; Kingdom J; Silverman E
    J Am Coll Cardiol; 2010 Jun; 55(24):2778-84. PubMed ID: 20538173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and management of fetuses at risk for, or affected by, congenital heart block associated with autoantibodies to SSA (Ro), SSB (La), or an HsEg5-like autoantigen.
    Claus R; Hickstein H; Külz T; Lenschow U; Meiske D; Kotitschke A; Thiesen HJ; Lorenz P
    Rheumatol Int; 2006 Aug; 26(10):886-95. PubMed ID: 16402218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perinatal outcome of fetus with isolated congenital second degree atrioventricular block without maternal anti-SSA/Ro-SSB/La antibodies.
    Chang YL; Hsieh PC; Chang SD; Chao AS; Liang CC; Soong YK
    Eur J Obstet Gynecol Reprod Biol; 2005 Oct; 122(2):167-71. PubMed ID: 16219517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and laboratory aspects of Ro/SSA-52 autoantibodies.
    Defendenti C; Atzeni F; Spina MF; Grosso S; Cereda A; Guercilena G; Bollani S; Saibeni S; Puttini PS
    Autoimmun Rev; 2011 Jan; 10(3):150-4. PubMed ID: 20854935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome and growth of infants fetally exposed to heart block-associated maternal anti-Ro52/SSA autoantibodies.
    Skog A; Wahren-Herlenius M; Sundström B; Bremme K; Sonesson SE
    Pediatrics; 2008 Apr; 121(4):e803-9. PubMed ID: 18381509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Ro52/SSA antibody-exposed fetuses with prolonged atrioventricular time intervals show signs of decreased cardiac performance.
    Bergman G; Eliasson H; Bremme K; Wahren-Herlenius M; Sonesson SE
    Ultrasound Obstet Gynecol; 2009 Nov; 34(5):543-9. PubMed ID: 19795521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing fetal cardiac conduction in anti-Ro/SSA-positive pregnancies.
    Sonesson SE; Hedlund M; Ambrosi A; Wahren-Herlenius M
    Rheumatology (Oxford); 2017 Oct; 56(10):1755-1762. PubMed ID: 28957562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fetal ECG: a novel predictor of atrioventricular block in anti-Ro positive pregnancies.
    Gardiner HM; Belmar C; Pasquini L; Seale A; Thomas M; Dennes W; Taylor MJ; Kulinskaya E; Wimalasundera R
    Heart; 2007 Nov; 93(11):1454-60. PubMed ID: 17085531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal congenital heart block.
    Yildirim A; Tunaoolu FS; Karaaoac AT
    Indian Pediatr; 2013 May; 50(5):483-8. PubMed ID: 23778728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventing congenital neonatal heart block in offspring of mothers with anti-SSA/Ro and SSB/La antibodies: a review of published literature and registered clinical trials.
    Gleicher N; Elkayam U
    Autoimmun Rev; 2013 Sep; 12(11):1039-45. PubMed ID: 23684701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of Maternal Autoantibodies with Fetal Congenital Heart Block.
    Madhusudan D; Raju A; Vijaya N
    J Obstet Gynaecol India; 2016 Oct; 66(Suppl 1):112-6. PubMed ID: 27651588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome in 212 anti-Ro/SSA-positive pregnancies and population-based incidence of congenital heart block.
    Skog A; Lagnefeldt L; Conner P; Wahren-Herlenius M; Sonesson SE
    Acta Obstet Gynecol Scand; 2016 Jan; 95(1):98-105. PubMed ID: 26411741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.